JP7804878B2 - タマサキツヅラフジ由来アルカロイド含有製剤 - Google Patents

タマサキツヅラフジ由来アルカロイド含有製剤

Info

Publication number
JP7804878B2
JP7804878B2 JP2023562123A JP2023562123A JP7804878B2 JP 7804878 B2 JP7804878 B2 JP 7804878B2 JP 2023562123 A JP2023562123 A JP 2023562123A JP 2023562123 A JP2023562123 A JP 2023562123A JP 7804878 B2 JP7804878 B2 JP 7804878B2
Authority
JP
Japan
Prior art keywords
derived
alkaloids
results
cepharanthine
novel coronavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023562123A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023089862A1 (https=
JPWO2023089862A5 (https=
Inventor
幸一 渡士
若奈 佐宗
徹 寺島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN INSTITUTE FOR HEALTH SECURITY
Sawai Pharmaceutical Co Ltd
Original Assignee
JAPAN INSTITUTE FOR HEALTH SECURITY
Sawai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN INSTITUTE FOR HEALTH SECURITY, Sawai Pharmaceutical Co Ltd filed Critical JAPAN INSTITUTE FOR HEALTH SECURITY
Publication of JPWO2023089862A1 publication Critical patent/JPWO2023089862A1/ja
Publication of JPWO2023089862A5 publication Critical patent/JPWO2023089862A5/ja
Application granted granted Critical
Publication of JP7804878B2 publication Critical patent/JP7804878B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2023562123A 2021-11-17 2022-07-04 タマサキツヅラフジ由来アルカロイド含有製剤 Active JP7804878B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021186784 2021-11-17
JP2021186784 2021-11-17
PCT/JP2022/026543 WO2023089862A1 (ja) 2021-11-17 2022-07-04 タマサキツヅラフジ由来アルカロイド含有製剤

Publications (3)

Publication Number Publication Date
JPWO2023089862A1 JPWO2023089862A1 (https=) 2023-05-25
JPWO2023089862A5 JPWO2023089862A5 (https=) 2024-07-10
JP7804878B2 true JP7804878B2 (ja) 2026-01-23

Family

ID=86396581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562123A Active JP7804878B2 (ja) 2021-11-17 2022-07-04 タマサキツヅラフジ由来アルカロイド含有製剤

Country Status (6)

Country Link
US (1) US20240299481A1 (https=)
EP (1) EP4434521A4 (https=)
JP (1) JP7804878B2 (https=)
CN (1) CN118555958A (https=)
TW (1) TW202320775A (https=)
WO (1) WO2023089862A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116253740A (zh) * 2021-12-10 2023-06-13 中国科学院上海药物研究所 环状双苄基异喹啉类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12022553084A1 (en) * 2020-05-14 2024-03-25 Kowa Co Novel inhalant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
bioRxiv，2020年，doi: https://doi.org/10.1101/2020.04.14.039925
signal transduction and targeted therapy，2021年03月23日，6:131

Also Published As

Publication number Publication date
US20240299481A1 (en) 2024-09-12
EP4434521A1 (en) 2024-09-25
JPWO2023089862A1 (https=) 2023-05-25
TW202320775A (zh) 2023-06-01
WO2023089862A1 (ja) 2023-05-25
EP4434521A4 (en) 2025-11-05
CN118555958A (zh) 2024-08-27

Similar Documents

Publication Publication Date Title
Faisal et al. Alkaloids as potential antivirals. A comprehensive review
CN114191553B (zh) 抗新型冠状病毒SARS-CoV-2的药物及其应用
TWI907588B (zh) 草藥組成物、其製備方法及將其投藥用於預防或治療病毒感染的方法
KR102456294B1 (ko) 코로나바이러스 감염 예방 및 치료용 약학 조성물
WO2016169573A1 (en) Sesquiterpene lactones as potent and broad spectrum antiviral compounds against all genotypes of hepatitis c virus (hcv)
CN111420024B (zh) 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CA2760530A1 (en) Neuroprotective ganoderma compositions and methods of use
KR102769170B1 (ko) 항 간염 바이러스 의약품 제조를 위한 암렉사녹스의 용도
KR102548616B1 (ko) 관중 유래 화합물 또는 이의 유도체를 포함하는 코로나바이러스 감염 예방 및 치료용 약학 조성물
US20240299481A1 (en) Stephania cepharantha-derived alkaloid-containing preparation
EP2865380A1 (en) Application of inula lineariifolia lactone a in preparation of medicine for treating myocarditis
JPWO2023089862A5 (https=)
WO2021203706A1 (zh) 膦甲酸钠在制备预防和治疗冠状病毒的药物中的应用
CN101416958A (zh) 15-亚甲基取代穿心莲内酯衍生物在制备抗乙型肝炎药物中的用途
CN102631384B (zh) 石榴在制备治疗或预防乙型肝炎病毒感染药物中的应用
CN106038695B (zh) 鳄梨萃取物、鳄梨醇b及(2r,4r)-1,2,4-三羟基十七碳-16-炔的用途，以及包含鳄梨萃取物的保健食品
CN113975268B (zh) 5,6-dehydroeurycomalactone在制备抗登革病毒药物的应用
Zhang et al. Delayed administration of Jiuwei Qianghuo Decoction combined with Zhuye Shigao Decoction mitigates the severity of influenza A virus infection by inhibiting cell death and alleviating the subsequent cytokine storm response
CN115105519A (zh) 用于治疗乙型肝炎的药物组合物及其制备方法
CN113908160A (zh) 小檗胺在抗结核分枝杆菌药物中的应用
AU2017210921B2 (en) Composition and combined medication method for treating enterovirus infection
Manap Pharmacological effect of agarwood essential oil (AEO) extract as anti-viral agent against hepatitis B virus
CN103565970B (zh) 一种治疗艾滋病的地榆提取物及其制备方法
TWI504402B (zh) 大戟科植物活性物質及其應用
TW201231061A (en) Schisandra chinensis extract capable of inhibiting or preventing H1N1 influenza virus infection and application thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240424

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250422

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250619

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20250820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250821

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250820

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251223

R150 Certificate of patent or registration of utility model

Ref document number: 7804878

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150